Beatty Laboratory: In the News
Read the latest news and advances by the Beatty Laboratory
FDA-ACCR Workshop on non-clinical models for safety assessment of immuno-oncology products
Gregory Beatty MD PhD to speak at FDA-AACR Workshop on evaluating immunotherapy toxicities in syngeneic immunocompetent mouse models on Sept 6, 2018 in Washington, DC
Gregory Beatty, MD PhD named honorary co-chair for the 2018 Purplestride Philadelphia to be held on Nov 3, 2018.
Combining two innate immune agonists induces potent anti-tumor immunity against an immunologically “cold” tumor
Beatty Laboratory presents preclinical data showing synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 agonist in a pancreatic cancer model. Data presented at Keystone Symposia and Annual AACR Meeting 2018.